Technical Analysis for MOR - MorphoSys AG
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 17.94 | -0.22% | -0.04 |
MOR closed down 0.22 percent on Tuesday, May 7, 2024, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: May 16
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Flat | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Narrow Range Bar | Range Contraction | 2.63% | |
New 52 Week Closing High | Bullish | 2.57% | |
Narrow Range Bar | Range Contraction | 2.57% | |
Doji - Bearish? | Reversal | 2.57% | |
Wide Bands | Range Expansion | 2.57% | |
Overbought Stochastic | Strength | 2.57% | |
New 52 Week Closing High | Bullish | 2.93% | |
Narrow Range Bar | Range Contraction | 2.93% | |
Wide Bands | Range Expansion | 2.93% | |
Overbought Stochastic | Strength | 2.93% |
Alert | Time |
---|---|
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock. |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/16/2024
MorphoSys AG engages in the development of therapeutic antibodies to cure inflammatory and autoimmune diseases, as well as cancer and infectious diseases. The company operates through two business segments; Partnered Discovery and Proprietary Development.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Immunology Infectious Diseases Antibodies Autoimmune Disease Antibody Autoimmunity Inflammatory And Autoimmune Diseases Evotec Morphosys
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Immunology Infectious Diseases Antibodies Autoimmune Disease Antibody Autoimmunity Inflammatory And Autoimmune Diseases Evotec Morphosys
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 18.305 |
52 Week Low | 4.185 |
Average Volume | 471,224 |
200-Day Moving Average | 11.12 |
50-Day Moving Average | 17.95 |
20-Day Moving Average | 17.92 |
10-Day Moving Average | 17.82 |
Average True Range | 0.24 |
RSI (14) | 53.27 |
ADX | 26.18 |
+DI | 20.53 |
-DI | 27.43 |
Chandelier Exit (Long, 3 ATRs) | 17.49 |
Chandelier Exit (Short, 3 ATRs) | 17.75 |
Upper Bollinger Bands | 18.35 |
Lower Bollinger Band | 17.49 |
Percent B (%b) | 0.53 |
BandWidth | 4.82 |
MACD Line | 0.01 |
MACD Signal Line | 0.03 |
MACD Histogram | -0.0244 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 18.17 | ||||
Resistance 3 (R3) | 18.18 | 18.12 | 18.13 | ||
Resistance 2 (R2) | 18.12 | 18.06 | 18.11 | 18.12 | |
Resistance 1 (R1) | 18.03 | 18.02 | 18.07 | 18.02 | 18.11 |
Pivot Point | 17.96 | 17.96 | 17.98 | 17.96 | 17.96 |
Support 1 (S1) | 17.87 | 17.90 | 17.92 | 17.86 | 17.77 |
Support 2 (S2) | 17.81 | 17.87 | 17.80 | 17.76 | |
Support 3 (S3) | 17.72 | 17.81 | 17.75 | ||
Support 4 (S4) | 17.71 |